
Chandan Healthcare Ltd is Rated Sell
2026-08-29 10:10:14Chandan Healthcare Ltd is rated Sell by MarketsMOJO, with this rating last updated on 10 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 August 2026, providing investors with the latest insights into its performance and outlook.
Read full news article
Chandan Healthcare Ltd Faces Mildly Bearish Momentum Amid Technical Downgrade
2026-08-20 08:05:48Chandan Healthcare Ltd, a micro-cap player in the hospital sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Recent technical indicators reveal a complex interplay of signals, with some suggesting cautious optimism while others point to emerging downside risks. This nuanced technical landscape warrants close attention from investors navigating the stock’s volatile trajectory.
Read full news article
Chandan Healthcare Ltd is Rated Sell
2026-08-18 10:10:39Chandan Healthcare Ltd is currently rated Sell by MarketsMOJO, with this rating last updated on 10 August 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 August 2026, providing investors with the most up-to-date view of the company’s fundamentals and market performance.
Read full news article
Chandan Healthcare Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-08-17 08:04:01Chandan Healthcare Ltd, a micro-cap player in the hospital sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a recent 2.73% day gain, the company’s overall technical indicators present a mixed picture, reflecting both cautious optimism and underlying challenges amid broader market pressures.
Read full news articleAre Chandan Healthcare Ltd latest results good or bad?
2026-08-14 19:55:10Chandan Healthcare Ltd's latest financial results for Q4 FY26 reflect a complex operational landscape characterized by strong revenue growth alongside margin pressures. The company reported net sales of ₹75.58 crores, marking a year-on-year increase of 38.32% and a sequential growth of 16.26%. This performance underscores the company's successful market penetration in North India's diagnostic services sector, where it operates a network of pathology and radiology facilities. Net profit for the quarter reached ₹6.92 crores, representing a significant year-on-year growth of 64.76% and a sequential increase of 52.42%. However, despite these positive indicators, the operating margin experienced compression, declining to 16.45% from 18.21% in the previous quarter. This contraction suggests rising operational costs, particularly in employee expenses, which increased notably during the quarter. For the full fisc...
Read full news article
Chandan Healthcare Ltd is Rated Hold by MarketsMOJO
2026-08-07 10:11:24Chandan Healthcare Ltd is currently rated Hold by MarketsMOJO. This rating was last updated on 05 August 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 07 August 2026, providing investors with the most up-to-date view of the company’s fundamentals and market performance.
Read full news article
Chandan Healthcare Ltd Technical Momentum Shifts Amid Bearish Signals
2026-08-07 08:06:51Chandan Healthcare Ltd, a micro-cap player in the hospital sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite some mildly bullish signals on weekly indicators, the overall technical picture suggests caution for investors as the stock faces downward pressure amid a recent downgrade in its Mojo Grade from Sell to Hold.
Read full news article
Chandan Healthcare Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-08-06 08:06:35Chandan Healthcare Ltd, a micro-cap player in the hospital sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a recent day decline of 2.82%, the stock’s technical indicators present a complex picture, with some signals suggesting mild bullishness while others remain neutral or bearish. This article analyses the latest technical parameters, price momentum, and relative performance against the broader market to provide a comprehensive view for investors.
Read full news article
Chandan Healthcare Ltd is Rated Sell
2026-07-27 10:11:24Chandan Healthcare Ltd is rated Sell by MarketsMOJO, with this rating last updated on 07 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news articleCorporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






